Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Non-Current Assets: 2023-2025

Historic Non-Current Assets for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to $8.7 million.

  • Camp4 Therapeutics' Non-Current Assets fell 45.23% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year decrease of 45.23%. This contributed to the annual value of $11.9 million for FY2024, which is 20.15% down from last year.
  • Latest data reveals that Camp4 Therapeutics reported Non-Current Assets of $8.7 million as of Q3 2025, which was down 14.74% from $10.2 million recorded in Q2 2025.
  • Over the past 5 years, Camp4 Therapeutics' Non-Current Assets peaked at $15.9 million during Q3 2024, and registered a low of $8.7 million during Q3 2025.
  • Moreover, its 3-year median value for Non-Current Assets was $11.5 million (2024), whereas its average is $12.1 million.
  • Data for Camp4 Therapeutics' Non-Current Assets shows a maximum YoY tumbled of 45.23% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Camp4 Therapeutics' Non-Current Assets stood at $14.9 million in 2023, then declined by 20.15% to $11.9 million in 2024, then slumped by 45.23% to $8.7 million in 2025.
  • Its Non-Current Assets stands at $8.7 million for Q3 2025, versus $10.2 million for Q2 2025 and $11.1 million for Q1 2025.